14-day Premium Trial Subscription Sign Up For FreeGet Free

ContraFect Corporation Stock Forecast NASDAQ:CFRX

$2.36 (-3.28%)

Volume: 97k

Closed: Jan 21, 2022

Hollow Logo Score: -4.327

ContraFect Corporation Stock Forecast

$2.36 (-3.28%)

Volume: 97k

Closed: Jan 21, 2022

Score Hollow Logo -4.327

CFRX Stock Insider Trading NASDAQ:CFRX

Based on the 87 latest insides trades, we have calculated the insider power to be positive at a ratio of 66.769.

In total, the insiders bought 1 608 209 and sold 1 361 184 CFRX shares in the last 87 trades.

INSIDER POWER

66.769

Last 87 transactions
Buy: 1 608 209 | Sell: 1 361 184 (Shares)
Date Action Amount Person Type
May 18, 2021 Buy 25 000 Sucoff Cary Options (Right to Buy)
May 18, 2021 Buy 25 000 Barer Sol J Options (Right to Buy)
May 18, 2021 Buy 25 000 Low David N. Options (Right to Buy)
May 18, 2021 Buy 25 000 Aklog Lishan Options (Right to Buy)
May 18, 2021 Buy 25 000 Otto Michael J. Options (Right to Buy)
May 18, 2021 Buy 25 000 Gilman Steven C Options (Right to Buy)
Apr 08, 2021 Buy 80 000 Messinger Michael Options (Right to Buy)
Apr 08, 2021 Buy 80 000 Cassino Cara M Options (Right to Buy)
Apr 08, 2021 Buy 90 000 Cassino Cara M Options (Right to Buy)
Apr 08, 2021 Buy 254 000 Pomerantz Roger Options (Right to Buy)
Apr 08, 2021 Buy 70 000 Bogdanos Natalie Options (Right to Buy)
Feb 08, 2021 Buy 16 000 Barlow Jane F OPTIONS (RIGHT TO BUY)
Jun 15, 2020 Buy 16 000 Aklog Lishan Options (Right to Buy)
Jun 11, 2020 Buy 75 000 Messinger Michael Options (Right to Buy)
Dec 13, 2019 Buy 50 000 Sucoff Cary Common Stock, par value $0.0001 per share
Dec 13, 2019 Buy 5 000 Messinger Michael Common Stock, par value $0.0001 per share
Dec 13, 2019 Buy 300 000 Low David N. Common Stock, par value $0.0001 per share
Dec 04, 2018 Sell 600 000 Fosun Industrial Co., Ltd Common Stock
Dec 04, 2018 Sell 600 000 Shanghai Fosun Pharmaceutical (group) Co., Ltd. Common Stock
Jul 25, 2017 Buy 800 Gilman Steven C Common Stock, par value $0.0001 per share
Jul 25, 2017 Buy 400 Gilman Steven C Warrants (Right to Buy)
Jul 25, 2017 Buy 40 000 Barer Sol J Common Stock, par value $0.0001 per share
Jul 25, 2017 Buy 20 000 Barer Sol J Warrants (Right to Buy)
Jul 25, 2017 Buy 20 000 Low David N. Warrants (Right to Buy)
Jul 25, 2017 Buy 40 000 Low David N. Common Stock, par value $0.0001 per share
Jul 25, 2017 Buy 8 000 Otto Michael J. Common Stock, par value $0.0001 per share
Jul 25, 2017 Buy 4 000 Otto Michael J. Warrants (Right to Buy)
Jul 25, 2017 Buy 400 Pomerantz Roger Warrants (Right to Buy)
Jul 25, 2017 Buy 800 Pomerantz Roger Common Stock, par value $0.0001 per share
Jul 25, 2017 Buy 9 600 Ricciardi Lisa Common Stock, par value $0.0001 per share
INSIDER POWER

66.769

Last 87 transactions
Buy: 1 608 209 | Sell: 1 361 184 (Shares)

About ContraFect Corporation

ContraFect ContraFect Corporation, a biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT